课题基金 / 基金详情

Pilot & Feasibility Program

Pilot & Feasibility Program
飞行员
批准号：
10441452
负责人：
Holger Willenbring
金额：
$16.02万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
项目状态：
已结题
起止时间：
1996-12-01 至 2023-08-14
来源：
https://reporter.nih.gov/project-details/10441452
关键词：
Academic supportApplications GrantsAwardBenchmarkingBiotechnologyCellular Metabolic ProcessCoupledDNA SequenceDedicationsEnhancersEnsureFacultyFatty LiverFinancial SupportFundingGene ExpressionGeneticGoalsGrantHeartHepatocyteHepatologyInvestmentsJointsJournalsLeadershipLiverLongevityMedicineMentorshipModificationNatureOralProcessPublishingResearchResearch PersonnelScientistSomatotropinSourceSystems BiologyTalentsTechniquesTextilesUntranslated RNAWorkbasecancer cellclinical investigationcommunity centercommunity engagementexperienceimprovedin vivointerestmedical schoolsmembernovelprofessorprogramsrecruitsatisfactionstatisticssuccesstheories

项目摘要

项目成果

Holger Willenbring的其他基金

相关文献

中文摘要
翻译
项目摘要/摘要 - 加州大学旧金山分校肝脏中心 有关项目摘要/摘要，请参阅总体/概述部分。
英文摘要
PROJECT SUMMARY/ABSTRACT – UCSF LIVER CENTER For the project summary/abstract please refer to the OVERALL/OVERVIEW section.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next-generation human liver gene therapy
Next-generation human liver gene therapy
Targeting AAV vectors to cell types involved in alcohol-induced liver injury
Targeting AAV vectors to cell types involved in alcohol-induced liver injury